首页|基于肠道菌群探讨四逆汤治疗慢性心力衰竭心阳虚证的作用机制

基于肠道菌群探讨四逆汤治疗慢性心力衰竭心阳虚证的作用机制

扫码查看
目的:检测慢性心力衰竭大鼠以四逆汤治疗前后肠道菌群的变化,探讨四逆汤治疗慢性心衰心阳虚证作用机制。方法:24只大鼠分为正常对照组、模型对照组、四逆汤2。8 g/kg组、美托洛尔0。01 g/kg组。造模大鼠腹腔注射阿霉素1。5 mL/kg,1次/w,连续7w,制备慢性心衰心阳虚证模型。造模成功后,各组灌胃相应药物或者蒸馏水,1次/d,连续21 d。干预结束后取出新鲜粪便,进行高通量测序分析。结果:与正常对照组比较,模型对照组大鼠左心室射血分数(LVEF)和左心室缩短分数(LVFS)均显著下降(P<0。01),血清中NT-proBNP含量显著升高(P<0。01),肠道菌群中Patescibacteria与放线菌门比率显著降低(P<0。01),罗姆布茨菌比例下降(P<0。05),梭状芽胞杆菌、苏黎世杆菌属、Adlercreutzia属、Bacteroides、Bacteroides_Pectinophilus等有害菌或条件致病菌成为优势菌,肠道菌群结构、优势菌及各菌群丰度产生变化;与模型对照组比较,四逆汤2。8 g/kg组大鼠LVEF、LVFS显著升高(P<0。01),血清中NT-proBNP含量显著降低(P<0。01),肠道菌群中Patescibacteria与放线菌门比率明显升高(P<0。05),罗姆布茨菌、NK4A214_group、克里斯滕森菌属、候选单胞生糖菌属、norank_f_UCG-010比例明显升高(P<0。05),双歧杆菌属、苏黎世杆菌属、未分类的厚壁菌比例显著降低(P<0。05),粪杆菌真核菌属、罗姆布茨菌、Candidatus_Saccharimonas、Peptococcaceae、NK4A214、UCG-010、克里斯滕森菌、Faecalibaculum等有益菌成为优势菌,肠道菌群结构、优势菌及各菌群丰度产生正向调整,促进有益菌生长,抑制有害菌生长,这可能与四逆汤治疗心衰心阳虚证的作用机制有潜在关联。结论:四逆汤可能通过有效调整慢性心衰心阳虚证大鼠肠道菌群的结构、优势菌群及各菌群丰度从而改善心衰。
Mechanism of Sini Decoction(四逆汤)in Treating Chronic Heart Failure with Xinyangxuzheng(心阳虚证)Based on Intestinal Flora
Objective:To investigate the changes in intestinal flora before and after the treatment with Sini Decoction(四逆汤)in rats with chronic heart failure(CHF)and explore the mechanism of Sini Decoction in treating CHF with Xinyangxuzheng(心阳虚证).Methods:Twenty-four rats were divided into a normal control group,a model control group,a Sini Decoction(2.8 g/kg)group,and a metoprolol(0.01 g/kg)group.The rats for modeling underwent intraperitoneal injection of doxorubicin at 1.5 mL/kg once a week for 7 consecutive weeks to induce a CHF model with Xinyangxuzheng.After successful modeling,each group was orally administered the corresponding drugs or distilled water once a day for 21 days.Fresh fecal samples were collected after intervention for high-throughput sequencing analysis.Results:Compared with the normal control group,the model control group showed significant decreases in left ventricular ejection fraction(LVEF)and left ventricular fractional shortening(LVFS)(P<0.01),and a significant increase in serum NT-proBNP content(P<0.01).Furthermore,the ratio of Pa-tescibacteria to Actinobacteria in the intestinal flora was significantly reduced(P<0.01),the proportion of Romboutsia decreased(P<0.05),and harmful or conditionally pathogenic bacteria such as Clostridium,Turicibacter,Adlercreutzia,Bacteroides,Bacteroides_Pectinophilus and so on became dominant.leading to changes in the structure,dominant bacteria,and abundance of various bacterial groups in the gut.Compared with the model control group,the Sini Decoction(2.8 g/kg)group exhibited significant increases in LVEF and LVFS(P<0.01),a significant decrease in serum NT-proBNP content(P<0.01),a significant increase in the ratio of Patescibacteria to Actinobacteria in the intestinal flora(P<0.05),and positive adjustments in the structure,dominant bacteria,and abundance of various bacterial groups in the gut.the proportions of Romboutsia,NK4A214_group,Christensenellaceae_R7_group,Candidatus_Saccharimonas,norank_f_UCG-010 were sig-nificantly higher(P<0.05),the proportions of Bifidobacterium,Turicibacter,and unclassified_p_Firmicutes were significantly lower(P<0.05),and the beneficial bacteria of the norank_f__Eubacterium_coprostanoligenes,Romboutsia,Candidatus_Saccharimonas,Peptococcace-ae,NK4A214,UCG-010,Christensenellaceae_R7_group,Faecalibaculum and so on became dominant.Moreover,the growth of beneficial bacteria was promoted and the growth of harmful bacteria was inhibited,suggesting a potential association with the mechanism of Sini Decoc-tion in treating CHF with Xinyangxuzheng.Conclusion:Sini Decoction may improve CHF by effectively adjusting the structure of intestinal flora,dominant bacterial groups,and the abundance of various bacterial groups in CHF rats with Xinyangxuzheng.

Sini Decoction(四逆汤)Chronic heart failureIntestinal flora

张曦宁、董振华、赵震宇、杜刘思、胡志希、李琳

展开 >

湖南中医药大学,长沙 410208

湖南中医药大学中医诊断研究所,长沙 410208

四逆汤 慢性心力衰竭 肠道菌群

国家自然科学基金项目湖南省自然科学基金项目中医学一流学科开放基金长沙市自然科学基金湖南省中医药科研项目

822744122023JJ304532021ZYX03kq2208185B2023045

2024

中药药理与临床
中国药理学会 四川省中医药科学院

中药药理与临床

北大核心
影响因子:0.996
ISSN:1001-859X
年,卷(期):2024.40(1)
  • 59